Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Apply
Dato-DXd vs. Gemcitabine
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step